Comparative analysis of Nε-carboxymethyl-lysine and inflammatory markers in diabetic and non-diabetic coronary artery disease patients

doi:10.4239/wjd.v14.i12.1754

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1407)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-6) series.

Item

Count

PDF

WORD

HTML

808

Figures (1-2)

Tables (1-6)

106

Sum=1072

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

158

Sum=237

Dec 15, 2023 (publication date) through May 20, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Diabetes. Dec 15, 2023; 14(12): 1754-1765
Published online Dec 15, 2023. doi: 10.4239/wjd.v14.i12.1754

Full Size Figure Download Figure

Figure 1 Comparison of serum Nε-carboxymethyl-lysine, interleukin 6, tumor necrosis factor alpha, and nitric oxide between group I and II. A: Serum Nε-carboxymethyl-lysine (CML) level; B: Serum interleukin-6 (IL-6) level; C: Serum tumor necrosis factor-alpha (TNF-α) level; D: Serum nitric oxide. ^aBiochemical markers CML, IL-6, TNF-α, and nitric oxide showed a difference between diabetic coronary artery disease patients and non-diabetic coronary artery disease patients. *Significant difference of biochemical markers between Group I: Diabetic coronary artery disease patients; and Group II: Non-diabetic coronary artery disease patients.

Citation: Shrivastav D, Singh DD, Mir R, Mehra P, Mehta V, Dabla PK. Comparative analysis of Nε-carboxymethyl-lysine and inflammatory markers in diabetic and non-diabetic coronary artery disease patients. World J Diabetes 2023; 14(12): 1754-1765
URL: https://www.wjgnet.com/1948-9358/full/v14/i12/1754.htm
DOI: https://dx.doi.org/10.4239/wjd.v14.i12.1754